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Abstract
Background: Inflammation is a predominant characteristic of autoimmune diseases which is
characterized by the increased expression of pro-inflammatory cytokines. Soon to be published
work from our laboratory has shown that ingestion of Perna canaliculus prevents the development
of autoimmune diseases such as Systemic Lupus Erythematosus and rheumatoid arthritis in
laboratory animals. The current paper attempts to illustrate how Perna can alleviate inflammation
by modulating inflammatory cytokines, cyclooxygenase enzymes and Immunoglobulin-G (IgG)
levels.
Methods: In the present study, hydrochloric acid [HCl] and Tween-20 were used to develop
extracts of Perna. These extracts were assayed for protein content. Increasing concentrations of
these extracts were then tested in cell culture for modulation of inflammatory cytokine,
cyclooxygenase enzymes and IgG levels. Parallel tests were run using an available glycogen extract
of Perna as a comparison to our in-house laboratory preparations.
Results: Tween-20 Perna extracts were found to be more stable and less toxic in cell culture than
HCl digest of Perna. They also assayed higher in protein content that HCl extracts. Although both
extracts inhibited IgG production in V2E9 hybridomas, Tween-20 extracts were more consistent
in IgG suppression than HCl extracts. Overall Tween-20 extracts effectively decreased levels of
TNF-α, IL-1, IL-2 and IL-6 as observed using cytokine bioassays. Twenty micrograms of Tween-20
Perna extracts induced such significant decreases in inflammatory cytokine production that when
tested on sensitive cell lines, they very nearly abolished the decrease in viability induced by these
cytokines. Tween-20 extracts effectively inhibited both COX-1 and COX-2 cyclooxygenase
activity. As a comparison, the glycogen extract also demonstrated a similar though weaker effect
on COX-1 and COX-2 enzymes. The active components of both extracts (Tween-20 and glycogen)
were observed to possess molecular weights above 100 kDa. Although the anti-cytokine activity of
the Tween-20 extract was destroyed by Proteinase-K treatment, the anti-COX-1 and anti-COX-
2 activity of both the extracts were not sensitive to protease treatment.
Conclusion:  We have successfully demonstrated modulation in the levels of inflammatory
cytokines, cyclooxygenase enzymes and immunoglobulins by our in-house laboratory preparations
of Perna canaliculus, whereby suggesting an immunomodulatory role of Perna canaliculus in regulating
inflammation.
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Background
Autoimmune diseases include a wide spectrum of sys-
temic diseases such as systemic lupus erythematosus
(SLE) and rheumatoid arthritis (RA) [1,2]. The important
characteristic of all autoimmune syndromes is inflamma-
tion and the damage inflicted upon self-tissues mediated
by host cellular and/or humoral responses. Autoantibod-
ies are fundamental to all autoimmune diseases and are
products of auto-reactive B cells and plasma cells, which
in turn, are driven by a T helper subset 1 (Th1) immune
response [3]. T lymphocytes play a role in the disease
process by the stimulation of other immune cells via T
helper subset 2 (Th2) and/or direct cell-cell interaction [4-
6]. Cytokines also play a role in autoimmunity by stimu-
lating or regulating B and T cells, macrophages, and/or
dendritic cellular responses to antigenic stimulation [7]. It
is well established that inflammatory cytokines play
important roles in the development and pathogenesis of
autoimmune diseases such as RA and SLE [8-11]. These
factors overcharge or overwork the immune networks and
must be regulated by modulation or suppression. The
New Zealand green-lipped mussel (Perna canaliculus) con-
tains components that can act as natural immunomodu-
lators. Laboratory investigations of the freeze-dried extract
of Perna canaliculus have demonstrated that Perna extracts
decreased experimentally induced inflammation in carra-
geenan-induced edema of the rat hind footpad [12]. In
our laboratory, Perna has been shown to suppress the
development of collagen-induced arthritis (CIA) in the
rat, and has even reversed inflammation associated with
CIA in mice. Perna has been employed as a therapeutic
agent in arthritis with some degree of success [13-15].
However, evidence from other clinical trials utilizing
Perna products for rheumatoid arthritis (RA) and osteoar-
thritis (OA) have been conflicting with respect to the ther-
apeutic potential of Perna [14,16].
The exact mechanism of Perna's anti-inflammatory action
is unknown. There is some evidence that certain compo-
nents in Perna may inhibit prostaglandin synthesis via
production of prostaglandin synthetase inhibitors [17-
19]. Perna also contain the histamine blocker lysolecithin
that may contribute to its anti-inflammatory activity [20].
Omega 3 fatty acids in Perna canaliculus have been shown
to decrease inflammation [21,22]. Although many
authors have demonstrated various anti-inflammatory
mediators in Perna canaliculus, inconsistencies in thera-
peutic activity levels persist. These inconsistencies may be
due to the lack of standardized extraction / fractionation
protocols and the possible presence of many anti-inflam-
matory mediators in Perna canaliculus. Different
Protocols for preparing extracts of Perna powder, a freeze dried preparation of Perna canaliculus using either concentrated  HCl or 0.1% Tween-20 Figure 1
Protocols for preparing extracts of Perna powder, a freeze dried preparation of Perna canaliculus using either concentrated 
HCl or 0.1% Tween-20.
ACID EXTRACTION TWEEN-20 EXTRACTION
PERNA (1 g)
TREATED WITH 5 ml CONC. HCl ( pH 1.0)
FOR 5 HOURS WITH CONSTANT AGITATION
NEUTRALIZED WITH 0.1 & 1.0 N NaOH
EXTRACT FILTERED THROUGH
0.22 µ µ µ µ FILTER
PROTEIN CONTENT ESTIMATED
BY BRADFORD ASSAY
USED IN IN VITRO ASSAYS
PERNA (1 g)
TREATED WITH 5 ml 0.1% TWEEN-20 @ 4ºC 24 HOURS
WITH CONSTANT AGITATION
EXTRACT FILTERED THROUGH 0.22 µ FILTER
PROTEIN CONTENT ESTIMATED BY BRADFORD ASSAY
USED IN IN VITRO ASSAYSBMC Complementary and Alternative Medicine 2006, 6:1 http://www.biomedcentral.com/1472-6882/6/1
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approaches to extract and/or fractionate Perna have been
employed albeit with mild success [20-24].
Our paper discusses two extraction techniques for obtain-
ing Perna extracts and explores the effects of these extracts
on inflammatory cytokine production, cyclooxygenase
activity and IgG modulation in both lymphocytic cell
lines and B cell hybridomas.
Methods
Preparation of Perna canaliculus (Perna) extracts
We used two protocols to create extracts of the lyophilized
Perna powder (FoodScience Corp., Essex Jct., VT), the
commercially available freeze-dried powder of the New
Zealand green lipped mussel, Perna canaliculus. The first
method used concentrated hydrochloric acid (1 M HCl)
while the second employed Tween-20 (Figure 1). Acid
extraction proceeded by placing 1 g samples of freeze-
dried Perna powder in 250 ml beakers along with 5 ml of
concentrated HCl solution (pH 1.0) in a 37°C water bath
for 5 hours with constant agitation. The extracts were neu-
tralized with either 0.1 N or 1.0 N sodium hydroxide
(NaOH) and filtered through a series of filters leading to
0.22µ. The filtrate was then analyzed and adjusted for pro-
tein content by the Bradford assay prior to use in cell cul-
ture. Tween-20 extraction of Perna was performed by
treating 1 g samples of freeze-dried Perna with 5 ml of
0.1% Tween-20 solution for 24 hours at 4°C with con-
stant agitation. The samples were then filtered and
assayed for protein content as above before use in cell cul-
ture. Both HCl and Tween-20 extracts were adjusted to
yield a range of concentrations for use in cell culture
assays based on their protein content.
Cell Lines and Cell Culture
The cell lines used in this study were V2E9, THP-1, L-929,
U-937, A375.S2, Jurkat E6-1, EL-4, CTLL-2, LS174T, and
7TD1. Characteristics of each cell line including cytokine
production and/or sensitivity are presented in Table 1. All
the cell lines, with the exception of V2E9, were obtained
from the American Type Culture Collection (ATCC). V2E9
cell line, a B cell hybridoma constitutively secreting
mouse IgG against the β1 subunit of chicken integrin, was
obtained courtesy of Ellis Kline, Clemson University.
V2E9 cells grown in Ex-Cell 610 medium (JRH Bio-
sciences) supplemented in initial studies with 10% fetal
bovine serum (FBS, Gibco BRL) and 1% Antibiotic-
Antimycotic (Gibco BRL) and later adapted to grow in
serum-free media. All the other cell lines were cultured as
per ATCC recommendations with regard to media and
supplements. CTLL-2 and 7TD1 are cytokine-dependent
cell lines requiring the addition of Interleukin-2 (IL-2)
and IL-6 respectively. All cell lines were grown at 37°C in
a humidified 5% CO2 incubator, except for EL-4 mouse
thymoma cells which required 10% CO2.
Modulation of IgG production in V2E9 hybridoma cells 
(ELISA)
V2E9 cells were harvested, enumerated, and 1 ml of cells
in Ex-cell 610 media at a concentration of 5e6 cells/ml
were transferred into 24 well plates. One hundred µl of
varying dosages (containing 0 µg, 5 µg, 10 µg, 15 µg, 20
µg, and 25 µg protein) of Perna extract were added. An
additional 900 µl of Ex-cell media were added to bring the
total volume to 2 ml. After incubation at 37°C for 48
hours, supernatants of Perna-treated and untreated con-
trol cells were drawn off and assayed for IgG levels using
ELISA.
Goat affinity purified antibody to mouse IgG (Cappel,
Organon Teknika Corp.) was diluted in phosphate buff-
ered saline [PBS] (pH 7.4) to a concentration of 0.1 µg/µl.
Ninety-six well, high-affinity binding ELISA plates (Corn-
ing, NY) were coated with 100 µl of this buffered suspen-
sion for an hour at 37°C. The plates were placed for an
additional hour at room temperature (RT). The plates
were washed twice with PBS, blocked with freshly pre-
pared Blotto (Skim milk in PBS) for 60 minutes at 37°C,
rinsed twice with PBS, and blotted. One hundred µl of the
supernatants from the treatment and control wells were
added to the plates and allowed to incubate for an hour at
37°C. Following incubation, plates were rinsed twice with
Blotto and PBS. One hundred µl of peroxidase conjugate
goat affinity-purified antibody to mouse IgG (Cappel,
Organon Teknika Corp.) diluted 1:100 in PBS were added
to each well. Plates were incubated for 30 minutes at 37°C
and rinsed four times with Blotto and twice with PBS. One
hundred micro liters of fresh color developer [24.3 ml of
Table 1: List of cytokine producing cell lines and their corresponding responder cell lines
CELL LINES CYTOKINES PRODUCED RESPONDER CELL LINES
THP-1 TNF-α L-929 (sensitive to TNF-α)
U-937 IL-1 A375.S2 (sensitive to IL-1)
Jurkat E6-1 IL-2 CTLL-2 (Proliferates in presence of IL-2)
HT-2 (Proliferates in presence of IL-2)
EL-4 IL-2 CTLL-2 (Proliferates in presence of IL-2)
HT-2 (Proliferates in presence of IL-2)
LS 174T IL-6 7TD1 (Proliferates in presence of IL-6)BMC Complementary and Alternative Medicine 2006, 6:1 http://www.biomedcentral.com/1472-6882/6/1
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0.1 M citric acid (Sigma), 25.7 ml of 0.2 M Na2HPO4
(Fisher Scientific), 50 ml distilled water, 40 mg o-phe-
nylenediamine (Sigma) and 40 µl of 30% H2O2 (Fisher
Scientific)] was added to each well and allowed to react
for 20 minutes in the dark at RT. Reactions were termi-
nated by the addition of 50 µl of 2.5 M H2SO4 to each
well. The plates were read using a BIO-RAD benchmark
microplate reader at 490 nm.
Modulation of cytokine production in cell lines (Cytokine 
Bioassays)
Modulation of inflammatory cytokine production by
Perna was determined by cytokine bioassays [25-28].
Supernatants of Perna-treated and untreated cytokine pro-
ducing cell lines (producers) were added to indicator cell
lines specifically sensitive to one of the cytokines. Prolif-
eration or inhibition of these indicator cell lines signals
the extent of cytokine secretion by the producer cell lines.
The optimum cell number per well for each cell line was
determined by titration. The producer cell lines which
grow in cell suspension, THP-1, Jurkat E6-1, EL-4 and U-
937, were plated on 48 well plates at a concentration of
5e6 cells/well, whereas the adherent producer cell line,
LS174T, was plated at a concentration of 5e5 cells/well.
Suspension responder cell lines (CTLL-2 and 7TD-1) were
added at a concentration of 1e6 cells/well in a 96 well
plate, whereas the adherent responder cell lines, L-929
and A375.S2, were plated at concentrations of 3e4 cells/
well and 4e4 cells/well respectively. THP-1 cells, which
secrete tumor necrosis factor-alpha (TNF-α) when stimu-
lated with lipopolysaccharide (LPS), were treated with
varying concentrations (containing 0 µg, 5 µg, 10 µg, 15
µg, 20 µg, and 25 µg protein) of Perna for a period of 24
hours at 37°C in a humidified 5% CO2 incubator. Super-
natants from these cells were then added to the indicator
cell line L929 that is sensitive to TNF-α and incubated for
24 hours at 37°C in a humidified 5% CO2 incubator [29-
31]. After incubation, MTS-PMS solution, (Cell Titer 96
Aqueous Kit, Promega, Madison, WI) was added to each
well as recommended by the manufacturer [32]. Detec-
tion of cell proliferation or inhibition is based on a color-
imetric assay system utilizing the tetrazolium reagent,
Dose response effects of Perna (HCl extract) on IgG secretion in V2E9 hybridoma cells Figure 2
Dose response effects of Perna (HCl extract) on IgG secretion in V2E9 hybridoma cells. Each bars represents the mean ± SEM 
of data points from three independent experiments with triplicate wells. Columns representing 10 µg, 15 µg and 20 µg Perna 
concentrations are statistically different from the saline control (no Perna). P ≤ 0.01.
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MTS. MTS is reduced to a water soluble formazan dye, via
the alternate electron acceptor PMS (phenazine methosul-
phate) in the mitochondria of living cells. Samples are
read at 4 hours using a BIO-RAD benchmark microplate
reader at 490 nm. The amount of color produced is
directly proportional to the number of viable cells. The
experiments were carried out in triplicate and repeated
three to six times for each cytokine. Similarly, U-937 cells
which secrete Interleukin-1 (IL-1) constitutively were
treated with Perna and the supernatants added to the sen-
sitive cell line A375.S2 [33,34]. Likewise, Jurkat E6-1 and
EL-4 mouse thymoma cells which when stimulated with
Ionomycin and phorbol myristate acetate (PMA) respec-
tively secrete IL-2, were treated with Perna and the super-
natants were added to the responder cell line CTLL-2 [35-
38]. Finally, LS174T colon adenocarcinoma cells that con-
stitutively secrete IL-6 were treated with the Perna extracts
and the supernatants added to the responder 7TD1 cell
line [39-41].
Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-
2) Assay
COX-1 and COX-2 assays were performed using the color-
imetric Ovine Cyclooxygenase (COX) assay kit (Cayman
Chemical Company). Different dilutions of Perna extracts
(Tween-20 & Glycogen) were aliquoted into microfuge
tubes and lyophilized. The lyophilized samples were then
resuspended in Dimethyl Sulfoxide (DMSO) and diluted
Dose response effects of Perna (Tween-20 extract) on IgG secretion levels in V2E9 hybridoma cells Figure 3
Dose response effects of Perna (Tween-20 extract) on IgG secretion levels in V2E9 hybridoma cells. Each bar represents the 
mean ± SEM of data points from three independent experiments with triplicate wells. Columns representing 5 µg, 10 µg, 15 µg, 
20 µg and 25 µg Perna concentrations are statistically different from the saline control (no Perna). P ≤ 0.01.
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further to derive the appropriate concentrations for test-
ing. The assay was then performed as described in the
assay kit booklet.
Statistical analysis
The results were expressed as the means ± SEM of the
number of measurements (independent experiments)
shown. Statistical comparisons between dosage groups
were done using the paired t-test and a one-way ANOVA,
with P < 0.01 indicating significance.
Results
Perna canaliculus (Perna) extracts
Extracts of Perna was prepared using two procedures, one,
which uses concentrated HCl and the other a cationic
detergent, Tween-20 (Figure 1). Hydrochloric acid was
chosen initially for preparing an extract of Perna to simu-
late the acidic gastric conditions of Perna when it is taken
orally. Tween-20 which draws out membrane-bound pro-
teins was used on the premise that the active component
in Perna might be a protein moiety [22]. It was found that
Tween-20 extract yielded higher protein recovery levels
than HCl extract. Protein estimation was used as a quanti-
tative measure of extract recovery at the end of HCl diges-
tion and Tween-20 treatment and also as a standard for
measuring activity. The low amount of protein in HCl
extracts could be based on either the dilution effect of
neutralizing HCl with NaOH or the inability of HCl to
extract active proteins efficiently. Since protein content
was used as the standard to measure activity, HCl extracts
had to be concentrated prior to use in cell culture assays.
Extracts in the range of 0 µg, 5 µg, 10 µg, 15 µg, 20 µg, and
25 µg protein content were used in assays to determine
activity. The neutralized HCl extracts were toxic to the
cells at concentrations approaching 20 µg (~70–80% via-
bility), whereas Tween-20 extracts did not affect viability
of cells (>90% viability) even at concentrations greater
than 25 µg.
As a comparison to our in-house laboratory prepared
extracts, a commercially available extract of Perna canalic-
ulus was obtained from Aroma New Zealand Limited,
Christchurch, New Zealand. This extract is rich in glyco-
gen and obtained by enzymatic treatment and extraction
Effect of time course dependent protease treated Perna (Tween-20 extract) on IgG secretion levels in V2E9 hybridoma cells Figure 4
Effect of time course dependent protease treated Perna (Tween-20 extract) on IgG secretion levels in V2E9 hybridoma cells. 
Each bar represents the mean ± SEM of data points from three independent experiments with triplicate wells. Columns repre-
senting 6 hr, 18 hr and 24 hr protease treatments are statistically different from the saline control (no Perna). P ≤ 0.01.
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with aqueous ethanol. Insoluble components were sepa-
rated by centrifugation and the extract isolated from the
supernatant by lyophilization [42].
Modulation of IgG production in V2E9 hybridoma cells
Both HCl and Tween-20 extracts were compared for the
ability to modulate IgG antibody production in V2E9
hybridoma. Both extracts significantly decreased antibody
expression in the hybridoma (Figure 2, Figure 3). Maxi-
mum decreases of antibody levels (21%) were observed
for HCl extract containing 20 µg of protein, whereas
Tween-20 extract decreased antibody levels by 26% at
similar protein concentrations. To determine whether the
active component of Perna was associated with a protein
moiety, protease digestion with Proteinase-K of Tween-20
extracts from Perna was carried out over different time
periods. On addition of these digests to V2E9 cells, no
decrease in antibody production was observed (Figure 4).
Furthermore the decrease in inhibitory activity of Protein-
ase-K treated Perna extract was time dependent. IgG secre-
tion levels increased in parallel with the length of protease
pretreatment. This correlated with an increase in IgG lev-
els over baseline levels from -18.5% to -1.6%, over a 48-
hour protease treatment period. The proteolytic enzyme
apparently eliminated the component in the Perna
extract, which inhibited antibody production.
Modulation of inflammatory cytokine expression
Tween-20 extract of Perna was tested for its ability to mod-
ulate cytokine expression in cell lines. Cytokine bioassay
results (Figure 5, Figure 6, Figure 7, Figure 8 & Figure 9)
demonstrated the dose dependent effect of the Perna
extract in decreasing inflammatory cytokine levels. The
maximal effect for TNF-α was observed with 20 µg of
Perna extract wherein the cytokine level was decreased to
48% of control levels as observed by the proliferation rate
of L-929 cells (Figure 5). Similarly, in U-937 cells, which
secrete IL-1, as the concentration of Perna extract
expressed as protein increased from 5 µg to 20 µg, the
level of IL-1 secretion decreased as detected by an increase
in the viability and proliferation of A375.S2 cells (Figure
6). This corresponds to approximately a 10% decrease in
IL-1 levels over baseline controls following treatment with
20 µg of Perna. Comparable results were obtained with
Dose response effects of Perna (Tween-20 extract) on TNF-α secretion levels in THP-1 cell line Figure 5
Dose response effects of Perna (Tween-20 extract) on TNF-α secretion levels in THP-1 cell line. Each bar represents the mean 
± SEM of data points from three independent experiments with triplicate wells. Columns representing the different concentra-
tions are all statistically different from the stimulated but untreated control (no Perna). P ≤ 0.01.
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Perna-treated Jurkat E6-1 and EL-4 cells, which secrete IL-
2. Supernatants from these cell lines, when added to the
responder cell line CTLL-2, triggered a decline in prolifer-
ation of CTLL-2 due to decreased levels of IL-2. In Jurkat
E6-1, secretion levels of IL-2 as evidenced by the prolifer-
ation of CTLL-2 cells dropped from a high of 23.56% to a
low of 2.98% (Figure 7). This translates to a drop of 21%
with 20µg of Perna extract. In EL-4 mouse thymoma cells,
IL-2 secretion levels as measured by the growth rate of
CTLL-2 cells reduced from 15.38% to 0.89% with the
highest growth rate drop of 14% observed with 20 µg
Perna (Figure 8). Likewise IL-6 production levels in
LS174T were also depressed in the presence of Perna
extract, leading to a drop in proliferation of 13% in 7TD1
cells (Figure 9).
Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-
2) Assay
We examined the effects of the Tween-20 extract of Perna
on the activity of both COX-1 and COX-2 enzymes.
Included in parallel studies was the glycogen rich com-
mercial extract derived from Aroma New Zealand. As
observed in figure 10, COX-1 activity was inhibited by
over 50%, when Perna extracts were tested. The magni-
tude of COX-1 inhibition was higher in dilutions from
Tween-20 extracts (1:200 and 1:400 dilutions) compared
to the Glycogen extracts (1:10 and 1:100 dilutions). Inhi-
bition of both the COX-1 and COX-2 enzyme activity was
consistently higher in all Tween-20 preparations (Figure
10).
Discussion
Inflammation is a prominent feature of autoimmunity
leading to tissue injury. Cytokines play an important role
in inflammatory autoimmune diseases such as RA and
SLE [43]. Elevated local and systemic levels of inflamma-
tory cytokines are often associated with depressed levels of
anti-inflammatory cytokines, which suppress inflamma-
tory pathways suggesting an aberrant Th1/Th2 regulation.
Current research on immunomodulation focuses on the
Dose response effects of Perna (Tween-20 extract) on IL-1 secretion levels in U-937 cell line Figure 6
Dose response effects of Perna (Tween-20 extract) on IL-1 secretion levels in U-937 cell line. Each bar represents the mean ± 
SEM of data points from three independent experiments with triplicate wells. Columns representing the different concentra-
tions are statistically different from the stimulated but untreated baseline controls (no Perna). P ≤ 0.01.
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ability of agents to regulate or modify the immune net-
work via regulation of Th1/Th2 immune responses. Natu-
ral substances such as hormones, vitamins, and amino
acids have been used to achieve this modulation [44,45].
Perna canaliculus has been a popular nutritional supple-
ment for treating arthritis. Oral consumption of Perna
stems from the observation that native New Zealanders
(Maoris) who lived near the sea had a much lower inci-
dence of arthritis than their relatives who lived inland
[46]. Both the diets were similar with the exception that
the Maoris on the coast consumed large amounts of green-
lipped mussel. Various researchers have experimented
with a range of methodologies for generating Perna canal-
iculus extracts and have demonstrated the presence of var-
ious anti-inflammatory mediators [21,22,47,48].
Inconsistencies in the therapeutic availability of the active
components in these preparations still persist and may be
due to the presence of many anti-inflammatory mediators
in Perna canaliculus. Different approaches to extract and/or
fractionate Perna have been employed albeit with mild
success [20-24]. Hence, we developed simple extraction
protocols using HCl and Tween-20 for generating soluble
extracts of the commercially available freeze-dried powder
of Perna canaliculus as a means to isolate, test and identify
some of the active components. Our rationale behind
using Hydrochloric acid (HCl) as an extraction tool stems
from our understanding of the primary route of Perna
intake which is ingestion. This is based primarily on our
laboratory studies related to collagen induced arthritis
(CIA) experiments involving rats and mice, where we
observed a delay in the onset of arthritis in animals that
were given Perna orally (manuscript in preparation). Sim-
ilar observations have been made by other investigators
Dose response effects of Perna (Tween-20 extract) on IL-2 secretion levels in Jurkat E6-1 cell line Figure 7
Dose response effects of Perna (Tween-20 extract) on IL-2 secretion levels in Jurkat E6-1 cell line. Each bar represents the 
mean ± SEM of data points from three independent experiments with triplicate wells. Columns representing 10 µg, 15 µg and 
20- µg concentrations of Perna are statistically different from the stimuated but untreated baseline control (no Perna). P ≤ 
0.01.
0
5
10
15
20
25
I
L
-
2
S
e
c
r
e
t
i
o
n
L
e
v
e
l
s
(
%
o
f
v
i
a
b
l
e
C
T
L
L
-
2
c
e
l
l
s
o
v
e
r
u
n
t
r
e
a
t
e
d
c
o
n
t
r
o
l
)
Increasing Concentrations of Perna
IL-2 Secretion Levels in Perna (Tween-20 Extract) Treated Jurkat E6-1 Cells
5µ µ µ µg1 0 µ µ µ µg1 5 µ µ µ µg2 0 µ µ µ µg ControlBMC Complementary and Alternative Medicine 2006, 6:1 http://www.biomedcentral.com/1472-6882/6/1
Page 10 of 15
(page number not for citation purposes)
with the oral administration of either Perna canaliculus or
Perna extracts in alleviating symptoms of arthritis and
other autoimmune diseases [47-51] These observations
led to the assumption that the active principle may be
facilitated by the digestive process. Hence we simulated
the acidic environment of the stomach by using hydro-
chloric acid (HCl) to extract Perna. Tween-20 is a cationic
detergent and was used based on the assumption and
prior evidence from Miller et al., that the anti-inflamma-
tory principle may be associated with a protein moiety
[22]. We found that Tween-20 extraction of Perna was
more stable and less toxic in cell culture than HCl digest
of Perna. The total protein content of HCl extract was
lower and more variable than Tween-20 extract due to the
elaborate nature of the HCl extraction process. Neutraliza-
tion with NaOH after HCl treatment dilutes this extract,
requiring removal of water by lyophilization to achieve
parity in protein content prior to use in cellular assays.
This concentration process led to an increase in osmolar-
ity and contributed towards decreased cellular viability.
Tween-20 being a cationic detergent and when used at a
concentration of 0.1% did not affect the viability of cells
(>90% viability) even at standard protein concentrations
as high as 25 µg. Thus, Tween-20 extracts was the preferred
method of extraction in all cytokine bioassays. Although
the extract derived from HCl digestion of Perna was not as
active as that obtained from similar treatment with
Tween-20, our results demonstrate that the anti- inflam-
matory properties were conserved in both extraction proc-
esses.
Perna extracts inhibited IgG production in the V2E9
hybridoma cell line. Tween-20 extract was more consist-
ent in IgG suppression than the HCl fraction. In RA and
SLE, the pathological antibody associated with disease
manifestations is of the IgG2a isotype which is produced
Dose response effects of Perna (Tween-20 extract) on IL-2 secretion levels in EL-4 mouse thymoma cells Figure 8
Dose response effects of Perna (Tween-20 extract) on IL-2 secretion levels in EL-4 mouse thymoma cells. Each bar represents 
the mean ± SEM of data points from three independent experiments with triplicate wells. Columns representing the different 
concentrations are statistically different from the stimuated but untreated baseline control (no Perna). P ≤ 0.01.
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under the influences of TNF-α and IL-1, mediators of the
inflammatory T-helper 1 (Th1) cellular response.
Although there is no direct correlation between IgG levels
of V2E9 hybridoma and pathological antibody of autoim-
mune disease, we infer that decreases in IgG levels may
mirror an improvement in pathological antibody.
Cytokine bioassays were used to ascertain a role for Perna
in modulating inflammatory cytokine production. Over-
all Tween-20 extracts effectively decreased levels of TNF-α,
IL-1, IL-2 and IL-6. Twenty µg of Tween-20 Perna extracts
induced significant decreases in inflammatory cytokine
production, which when tested on sensitive cell lines, very
nearly abolished the decrease in viability induced by most
inflammatory cytokines (TNF-a, IL-1 & IL-6). Although
some of the changes in cytokine expression reported via
the bioassay may appear to be numerically small, they
represent relatively large changes in percentage. In the
case of IL-1, the level of IL-1 production in U-937 pro-
ducer cell line led to a 10% decrease in viability of the sen-
sitive responder cell line (A375.S2). This 10% decrease in
A375.S2 viability is reflective of the level of IL-1 produced
by U-937. This is the control expression level of IL-1 and
termed as IL-1 control, where there was no Perna treat-
ment. Using this as our baseline level for normal IL-1
expression, we found that increasing concentrations of
Tween-20 Perna extracts led to an increase in responder
cell (A375.S2) viability. In other words, 10 µg of Tween-
20 Perna extract decreased the levels of IL-1 secretion in U-
937 which in turn led to a 2.5% decrease in A375.S2 via-
bility as compared to an observed 10% decrease in the
control. This translates to at least 4-fold decrease in IL-1
expression levels. Similarly when 20 µg of Perna extract
was tested in the bioassay, the viability of A375.S2
increased near 100%. This lack of decrease in viability of
A375.S2 is reflective of the absence of any IL-1 production
Dose response effects of Perna (Tween-20 extract) on IL-6 secretion levels in LS 174T cell line Figure 9
Dose response effects of Perna (Tween-20 extract) on IL-6 secretion levels in LS 174T cell line. Each bar represents the mean 
± SEM of data points from three independent experiments with triplicate wells. Columns representing 10 µg, 15 µg and 20- µg 
concentrations of Perna are statistically different from the stimuated but untreated baseline control (no Perna). P ≤ 0.01.
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50% inhibition of Cox-1 (Figure A.) and Cox-2 (Figure B.) was seen between the 1:200 and 1:400 dilutions of the Tween-20  extract and between the 1:10 and 1:100 dilutions of the Glycogen Extract Figure 10
50% inhibition of Cox-1 (Figure A.) and Cox-2 (Figure B.) was seen between the 1:200 and 1:400 dilutions of the Tween-20 
extract and between the 1:10 and 1:100 dilutions of the Glycogen Extract.
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by U-937 cell line in presence of 20 µg of Perna extracts.
This observed decrease in IL-1 expression although small
as measured by cytokine bioassays was repeatable in at
least four independent experiments. Minor cytokine
changes tend to become significant when complex net-
worked systems in living organisms are involved. Similar
changes in cytokine profiles that are enough to alter the
therapeutic outcome have been observed in mouse mod-
els of rheumatoid arthritis and Systemic lupus erythema-
tosus [52]. This decrease in inflammatory cytokines may
help to explain the delayed onset of arthritis and the
reversal of arthritic inflammation observed in the collagen
induced arthritis (CIA) experiments involving rats and
mice in our laboratory (manuscript in preparation). The
ability of Perna to decrease inflammatory cytokine levels
is relevant in control of Th1 mediated immune responses.
The effect of Perna in decreasing IgG levels in V2E9 asso-
ciated with observed decreases in inflammatory cytokine
production might mimic amelioration of pathological
factors in autoimmune diseases.
Treatment of the extract with protease removed the active
component of the soluble fraction and made Perna inef-
fective in modulating IgG production. This suggests that
the active component in Perna may be associated with a
protein moiety. This corroborates with the work done by
Miller et al., who showed Perna to possess an anti-inflam-
matory glycogen component associated with a protein
moiety, probably as a glycoprotein [22].
We used a commercially available extract of Perna canal-
iculus obtained from Aroma New Zealand Limited,
Christchurch, New Zealand as a comparison to our in-
house laboratory preparations. This extract is reported to
be rich in glycogen and has been obtained by enzymatic
treatment followed by extraction with aqueous ethanol
and is now called the Glycogen extract [42]. This glycogen
extract was found to decrease foot pad edema (inflamma-
tory edema) which had been induced by carrageen in rats
[22]. In preliminary studies we found that the active com-
ponent of both the Tween-20 and glycogen extracts had
molecular weights above 100 kDa. Anti-inflammatory
cytokine activity was destroyed on treatment of the
Tween-20 extract with Proteinase-K. A similar digestion
eliminated the anti-inflammatory activity of the glycogen
extract in the Carrageen induced edema model in rats
[22].
In evaluating the anti-inflammatory potential of our
Perna extracts, we have performed the colorimetric Ovine
Cyclooxygenase (COX) assay. We have successfully dem-
onstrated that Tween-20 extracts of Perna canaliculus was
effective in inhibiting both COX-1 and COX-2 cyclooxy-
genase activity. As a comparison, the glycogen extract also
demonstrated a similar though weaker effect on COX-1
and COX-2 enzymes. COX enzymes are essential in the
inflammatory process and control the downstream regu-
lation of immune cell activation and inflammatory
cytokine induction [53]. Currently a great deal of atten-
tion is being paid to understanding the multifaceted
nature of the cyclooxygenase and the lipooxygenase path-
ways in inflammation and cytokine induction. Our results
demonstrating the inhibition of Ovine COX-1 and COX-
2 have supported the role played by Perna extracts in
modulating inflammation and inflammatory cytokine
response.
Conclusion
In summary, we have prepared two distinct extracts of the
freeze dried Perna powder. The Tween-20 extract was
determined to be more potent and less toxic than HCl
extract in decreasing IgG expression in hybridoma cell cul-
ture. Consequently we used the Tween-20 extracts in all
subsequent experiments involving modulations of
inflammatory cytokine expression and cyclooxygenase
activity. Tween-20 Perna extracts were shown to suppress
pro-inflammatory cytokines expression, inhibit COX-1
and COX-2 activity and decrease IgG levels. In parallel
studies using glycogen extracts, we observed similar
decline in COX-1 and COX-2 activity. Although, both the
extracts (glycogen and Tween-20) possessed active com-
ponents that appeared to be larger than 100 kDa, the com-
ponent effective against inflammatory cytokines was
sensitive to proteolysis using Proteinase-K and Pronase,
whereas the component effective against COX enzymes
was resistant to proteolysis. Based on all the above obser-
vations, we suggest a possible immunomodulatory role
for Perna canaliculus in mediating Th1/Th2 regulation as it
relates to inflammation.
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